Study Stopped
Discontinuation of the development
An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of this study is to evaluate of the long-term safety and efficacy of KCT-0809 in dry eye patients with Sjögren's syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 17, 2015
CompletedFirst Posted
Study publicly available on registry
July 20, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 29, 2017
CompletedMarch 5, 2018
March 1, 2018
July 17, 2015
March 2, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidences of adverse events
52 weeks
Secondary Outcomes (1)
Score of the corneal staining
52 weeks
Study Arms (1)
KCT-0809
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Dry eye patients with Sjögren's syndrome finished KCT1301 study
You may not qualify if:
- Patients with poor adherence to medication of study drug in KCT1301 study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Unknown Facility
Multiple Locations, Japan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 17, 2015
First Posted
July 20, 2015
Primary Completion
May 29, 2017
Last Updated
March 5, 2018
Record last verified: 2018-03